{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,22]],"date-time":"2026-11-22T01:40:08Z","timestamp":1795311608257,"version":"4.10.3"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12_suppl_4","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2006,12,26]]},"DOI":"10.1212\/wnl.67.12_suppl_4.s39","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:42:49Z","timestamp":1336920169000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Optimizing therapy of seizures in adult patients with psychiatric comorbidity"],"prefix":"10.1212","volume":"67","author":[{"given":"Eylert","family":"Brodtkorb","sequence":"first","affiliation":[{"name":"From the Department of Neurology and Clinical Neurophysiology, St. Olav's Hospital, Trondheim University Hospital and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway (Dr. Brodtkorb) and Department of Neurology, Amedeo Avogadro University, Novara and Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Italy (Dr.Mula)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mula","sequence":"additional","affiliation":[{"name":"From the Department of Neurology and Clinical Neurophysiology, St. Olav's Hospital, Trondheim University Hospital and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway (Dr. Brodtkorb) and Department of Neurology, Amedeo Avogadro University, Novara and Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Italy (Dr.Mula)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2004.00324.x"},{"key":"e_1_3_1_3_2","first-page":"53","volume":"53","year":"1999","unstructured":"Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53(suppl 2):53\u201367.","journal-title":"Neurology"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225020-00004"},{"key":"e_1_3_1_5_2","first-page":"9","volume":"58","year":"2002","unstructured":"Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(suppl 5):9\u201320.","journal-title":"Neurology"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2005.06.008"},{"key":"e_1_3_1_7_2","first-page":"34","volume":"7","year":"2005","unstructured":"Schachter SC. Improving quality of life beyond seizure control. Epileptic Disord 2005;7(suppl 1):34\u201338.","journal-title":"Epileptic Disord"},{"key":"e_1_3_1_8_2","first-page":"85","volume":"6","year":"2004","unstructured":"Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM, Corey LA. Which seizure-precipitating factors do patients with epilepsy most frequently report? Epilepsy Behav 2004;6:85\u201389.","journal-title":"Epilepsy Behav"},{"key":"e_1_3_1_9_2","first-page":"CD002029","volume":"4","year":"2003","unstructured":"Ramaratnam S, Baker GA, Goldstein L. Psychological treatments for epilepsy. Cochrane Database Syst Rev 2003;4:CD002029.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(03)00050-5"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-5069(02)00501-7"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2003.19103.x"},{"key":"e_1_3_1_13_2","first-page":"57","volume":"40","year":"1999","unstructured":"Krishnamoorthy ES, Trimble MR. Forced normalization: clinical and therapeutic relevance. Epilepsia 1999;40(suppl 10):57\u201364.","journal-title":"Epilepsia"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Brodtkorb E. Management of epilepsy in people with learning disability. In: Shorvon SD Perucca E Fish DR Dodson WE eds. The treatment of epilepsy. 2nd edition. Malden MA: Blackwell Science 2004","DOI":"10.1002\/9780470752463.ch17"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.036863"},{"key":"e_1_3_1_16_2","first-page":"23","volume":"180","year":"2003","unstructured":"Hirsch E, Schmitz B, Carreno M. Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol Scand 2003;180(suppl):23\u201332.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00909.x"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.3.1.1"},{"key":"e_1_3_1_19_2","first-page":"176","year":"2005","unstructured":"Nadkarni S, Devinsky O. Psychotropic effects of antiepileptic drugs. Epilepsy Currents 2005;5:176\u2013181.","journal-title":"Epilepsy Currents"},{"key":"e_1_3_1_20_2","first-page":"953","year":"2004","unstructured":"Mula M, Monaco F, Trimble MR. Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk. Expert Rev Neurotherapeutics 2004;4:953\u2013964.","journal-title":"Expert Rev Neurotherapeutics"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2004.07.005"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000117423.05703.e7"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.043s2037.x"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200209000-00012"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/15622970309167906"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169418.31275.a7"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(98)80074-5"},{"key":"e_1_3_1_28_2","first-page":"19","volume":"43","year":"2002","unstructured":"Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia 2002;43(suppl 2):19\u201324.","journal-title":"Epilepsia"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.9.1525"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevNeurobiol.v13.i4.10"},{"key":"e_1_3_1_31_2","first-page":"13","volume":"43","year":"2002","unstructured":"Schmitz B. Antidepressant drugs: indications and guidelines for use in epilepsy. Epilepsia 2002;43(suppl 2):13\u201318.","journal-title":"Epilepsia"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2005.05.014"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.11.1929"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-5050(03)00021-0"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.022392"},{"key":"e_1_3_1_36_2","first-page":"29","volume":"13","year":"2004","unstructured":"Reuber M, Andersen B, Elger CE, Helmstaedter C. Depression and anxiety before and after temporal lobe epilepsy surgery. Seizure 2004;13:29\u201335.","journal-title":"Seizure"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2003.11.013"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnn.0000117860.44205.78"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2005.01.004"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.05.024"},{"key":"e_1_3_1_41_2","first-page":"6","volume":"6","year":"2004","unstructured":"Schachter S. Vagus nerve stimulation: mood and cognitive effects. Epilepsy Behav 2004;6(suppl 1):6\u20139.","journal-title":"Epilepsy Behav"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.67.12_suppl_4.S39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:08:35Z","timestamp":1711541315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.67.12_suppl_4.S39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,26]]},"references-count":40,"journal-issue":{"issue":"12_suppl_4","published-print":{"date-parts":[[2006,12,26]]}},"alternative-id":["10.1212\/WNL.67.12_suppl_4.S39"],"URL":"https:\/\/doi.org\/10.1212\/wnl.67.12_suppl_4.s39","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,26]]}}}